
Meridian Bioscience VIVO
Quarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience Cash Conversion Cycle 2011-2026 | VIVO
Annual Cash Conversion Cycle Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 232 | 206 | 208 | 212 | 215 | 250 | 195 | 201 | 208 | 199 | 221 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 250 | 195 | 212 |
Quarterly Cash Conversion Cycle Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 266 | - | - | 163 | 194 | - | 283 | 245 | 186 | 118 | 198 | 159 | 225 | 113 | 213 | 220 | 220 | 108 | 222 | 215 | 209 | 107 | 215 | 45 | 50.1 | 52.6 | 48.8 | 53.3 | 52.1 | 50.9 | 49.7 | 48.2 | 44.5 | 45.4 | 44.9 | 43.5 | 49.6 | 48.8 | 50.7 | 50.9 | 48.3 | 50.8 | 52.6 | 48.5 | 55.6 | 54.8 | 56.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 283 | 43.5 | 115 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 17.01 | -0.12 % | $ 179 M | ||
|
Agilent Technologies
A
|
111 | $ 118.45 | 0.77 % | $ 36 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 428.08 | -0.52 % | $ 12.3 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.18 | -16.8 % | $ 387 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 8.94 | 0.85 % | $ 1.15 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.01 | -3.9 % | $ 403 M | ||
|
Natera
NTRA
|
81.5 | $ 217.95 | 5.41 % | $ 21.4 B | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.32 | 3.27 % | $ 20 B | ||
|
Personalis
PSNL
|
-11.5 | $ 6.09 | 9.53 % | $ 361 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
-398 | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 20.95 | 1.21 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 1.62 | 1.89 % | $ 2.15 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 473.95 | 1.56 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.61 | 2.11 % | $ 61.9 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 24.97 | 1.5 % | $ 694 M | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 59.92 | 5.68 % | $ 3.58 B | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 181.87 | -1.86 % | $ 9.01 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Waters Corporation
WAT
|
731 | $ 348.57 | 1.73 % | $ 20.8 B | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 15.0 | 0.67 % | $ 454 M | ||
|
Guardant Health
GH
|
79.6 | $ 92.69 | 3.54 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 124.47 | 2.6 % | $ 10.3 B | ||
|
Illumina
ILMN
|
142 | $ 142.25 | 2.29 % | $ 22.6 B | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 5.45 | 8.9 % | $ 227 M | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 2.11 | 5.09 % | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
172 | $ 2.17 | -0.69 % | $ 4.98 M | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 86.05 | 0.27 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 258.79 | 0.64 % | $ 21.5 B | ||
|
Exagen
XGN
|
-3.23 | $ 3.08 | -0.32 % | $ 66.4 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
150 | $ 9.18 | -1.02 % | $ 1.99 B |